These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4807573)

  • 41. Production of HL-A antisera by planned immunisations. Three new HL-A factors.
    Savi M; Garini G; Curtoni ES
    Proc Eur Dial Transplant Assoc; 1972; 9():475-83. PubMed ID: 4668923
    [No Abstract]   [Full Text] [Related]  

  • 42. Rat alloantibody responses against strong and weak histocompatibility antigens.
    Miller C; DeWitt C
    J Immunol; 1972 Nov; 109(5):919-26. PubMed ID: 5079095
    [No Abstract]   [Full Text] [Related]  

  • 43. Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Collins JJ; Genovesi EV; Livnat D; Sanfilippo F
    Cancer Res; 1981 Jun; 41(6):2407-15. PubMed ID: 7016314
    [No Abstract]   [Full Text] [Related]  

  • 44. A schema for immunotherapy.
    Bach FH; Bach ML; Zoschke DC
    Bibl Haematol; 1973; 39():910-5. PubMed ID: 4149724
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells.
    Watanabe T; Yagi Y; Pressman D
    J Immunol; 1971 May; 106(5):1213-21. PubMed ID: 5574404
    [No Abstract]   [Full Text] [Related]  

  • 47. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 48. [New understanding of immunologic control mechanisms of tumor growth].
    Sjögren HO
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1152-4. PubMed ID: 4341122
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells.
    Grant CK; Avis PJ; Hall JG; Alexander P
    Transplantation; 1971 Mar; 11(3):356-8. PubMed ID: 5558568
    [No Abstract]   [Full Text] [Related]  

  • 51. An indirect cytotoxicity test with increased sensitivity against the normal and leukaemic transplantation antigens.
    Motta R
    Rev Eur Etud Clin Biol; 1970 May; 15(5):510-4. PubMed ID: 5310725
    [No Abstract]   [Full Text] [Related]  

  • 52. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes.
    Cooper NR; Polley MJ; Oldstone MB
    J Immunol; 1974 Feb; 112(2):866-8. PubMed ID: 4855965
    [No Abstract]   [Full Text] [Related]  

  • 55. A sensitive in vitro microassay for detecting antibody-dependent cellular cytotoxicity. Possible role in monitoring lymphocyte function.
    Zighelboim J; Gale RP; Ossorio RC; Fahey JL
    Transplantation; 1974 Jul; 18(1):27-30. PubMed ID: 4546037
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of antigen density and non-complement fixing antibody on cytolysis by alloantisera.
    Basch RS
    J Immunol; 1974 Aug; 113(2):554-62. PubMed ID: 4846266
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of immunity in therapy of human cancer. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():299-308. PubMed ID: 4804287
    [No Abstract]   [Full Text] [Related]  

  • 58. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 59. Xenogeneic recognition of tumour spcific plasma membrane antigens derived from mouse lymphoma cells.
    Wolf A; Barfoot RK; Johnson RA
    Immunology; 1972 Mar; 22(3):485-91. PubMed ID: 5026856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on the effect of specific antisera on the metabolism of cellular antigens. I. Isolation of thymus leukemia antigens.
    Yu A; Cohen EP
    J Immunol; 1974 Apr; 112(4):1285-95. PubMed ID: 4815091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.